TriAct Therapeutics, Inc.

États‑Unis d’Amérique

 
Quantité totale PI 13
Rang # Quantité totale PI 116 558
Note d'activité PI 1,5/5.0    6
Rang # Activité PI 155 196

Brevets

Marques

6 0
1 0
6 0
0
 
Dernier brevet 2023 - Methods of treating glioblastoma
Premier brevet 2009 - Use of catecholic butane derivat...

Derniers inventions, produits et services

2022 Invention Methods of treating glioblastoma. Disclosed herein are methods and compounds for treating gliobl...
2021 Invention Methods of treating glioblastoma. Disclosed herein are methods and compounds for treating gliobla...
2018 Invention Iniparib formulations and uses thereof. Disclosed herein are pharmaceutical compositions, formula...
Invention Methods of patient selection and treating trxr- or prdx-overexpressed cancers. Disclosed herein ...
Invention Methods of patient selection and treating trxr- or prdx-overexpressed cancers. Disclosed herein a...
2014 Invention Cancer therapy. The present application relates to compositions and methods for treating a prolif...
Invention Cancer therapy. The present application relates to compositions and methods for treating a proli...
2009 Invention Catecholic butanes and use thereof for cancer therapy. The present application relates to composi...
Invention Use of catecholic butane derivatives in cancer therapy. The present application relates to compos...